CS logo
small CS logo
Clinica Baviera; Servicio Oftalmologia

Madrid, Spain

About Clinica Baviera; Servicio Oftalmologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Beaver-Visitec International, Inc.
1
Gyroscope Therapeutics Limited
1
Total Rows: 3

Clinical Trials at Clinica Baviera; Servicio Oftalmologia


During the past decade, Clinica Baviera; Servicio Oftalmologia conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111224400000000Started TrialsCompleted Trails20182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
2019-02-19
2022-01-18
Completed
671
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
2020-09-28
2025-09-17
Active, not recruiting
255
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
2021-07-14
2024-05-15
Recruiting
442
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
2021-03-02
2023-06-15
Active, not recruiting
553
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
PMCF Retrospective Study Outcomes of a Premium Monofocal IOL
2021-05-24
2022-01-12
Completed
109

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Baviera; Servicio Oftalmologia" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "targomedGmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 6Hoffmann-La Roche: 6Beaver-VisitecInternational, Inc.: 1Beaver-VisitecInternational, Inc.: 1GyroscopeTherapeutics Limited: 1GyroscopeTherapeutics Limited: 1

Created with Highcharts 11.1.0Top CollaboratorsChugai Pharmaceutical: 1Chugai Pharmaceutical: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1targomedGmbH: 1targomedGmbH: 1

Clinical Trials Conditions at Clinica Baviera; Servicio Oftalmologia


According to Clinical.Site data, the most researched conditions in "Clinica Baviera; Servicio Oftalmologia" are "Diabetic Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Cataract" (1 trials), "Dry Age-related Macular Degeneration" (1 trials) and "Lens Opacities" (1 trials). Many other conditions were trialed in "Clinica Baviera; Servicio Oftalmologia" in a lesser frequency.

Clinical Trials Intervention Types at Clinica Baviera; Servicio Oftalmologia


Most popular intervention types in "Clinica Baviera; Servicio Oftalmologia" are "Drug" (7 trials), "Procedure" (3 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Aflibercept" (3 trials), "GT005: High Dose" (1 trials) and "GT005: Medium Dose" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Clinica Baviera; Servicio Oftalmologia


The vast majority of trials in "Clinica Baviera; Servicio Oftalmologia" are 8 trials for "All" genders.

Clinical Trials Status at Clinica Baviera; Servicio Oftalmologia


Currently, there are NaN active trials in "Clinica Baviera; Servicio Oftalmologia". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinica Baviera; Servicio Oftalmologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinica Baviera; Servicio Oftalmologia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 4Active, not recruiting: 4Completed: 3Completed: 3Recruiting: 1Recruiting: 1